National Research Corporation

NASDAQ:NRC

Medical - Healthcare Information Services

Healthcare
$26.16 +0.40%

+$0.07 today

Market cap
$555.16M
Beta
0.40
P/E (TTM)
43.0
EPS (TTM)
$0.41
Dividend yield
3.14%
52W Low $11.01High $22.79

Volume 0.09M

Average 0.11M

NRC EBITDA Margin

EBITDA as a percentage of revenue.

National Research CorporationNASDAQ: NRC

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 22.4%

EBITDA Margin was 22.4% in Q1 FY2026, down 7.9 pp from a year earlier. On a trailing-twelve-month basis it was 20.1%, down 9.1 pp year over year. Over 3 fiscal years it narrowed by 10.5 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 32.1% for the fiscal year ending Dec 2026, up from 22.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
22.4%+3.1 pp QoQ
Last fiscal yearDec 2025
22.0%-6.9 pp YoY
LTMMar 2026
20.1%-9.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-7.9 pp-9.4 pp-1.5 pp
1 year-6.9 pp+10.1 pp+17.0 pp
3 years-10.5 pp+14.4 pp+24.9 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
22.0%
Year-over-year change
-6.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How NRC compares with its peers on the latest reported figures

  • NRC's LTM Mar 2026 EBITDA Margin of 20.1% is the 4th highest of the 8 companies compared; the peer median is 8.6%.
  • Its year-over-year change of -9.1 pp is the 7th highest of 8, against a peer median of +1.3 pp.
  • Over three fiscal years its change of -10.5 pp compares with a peer median of +8.3 pp.
NRC Competitors Peer median
EBITDA Margin for NRC and competitors
Company Period LTM level YoY 3-year change
CTEVClaritev CorporationLTM Mar 202652.9% +109.3 pp+34.6 pp
CCLDCareCloud, Inc.LTM Mar 202622.8% +1.3 pp+8.3 pp
HSTMHealthStream, Inc.LTM Mar 202622.4% +0.1 pp+1.9 pp
NRCNational Research CorporationLTM Mar 202620.1% -9.1 pp-10.5 pp
PHRPhreesia, Inc.LTM Apr 20268.6% +10.7 pp+57.9 pp
DHDefinitive Healthcare Corp.LTM Mar 20264.9% +295.3 pp-78.9 pp
HCATHealth Catalyst, Inc.LTM Mar 2026-63.6% -59.1 pp-5.5 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-81.4% -6.3 pp+87.8 pp
Peer median (excluding NRC) 8.6%+1.3 pp+8.3 pp

Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue147.95M151.57M148.58M143.06M137.39M
Cost of Revenue52.35M57.05M56.02M56.93M60M
Gross Profit95.6M94.52M92.57M86.13M77.4M
Gross Margin64.6%62.4%62.3%60.2%56.3%
Research & Development00000
Selling, General & Admin38.96M42.7M46.58M44.91M54.81M
Operating Expenses45.33M47.98M52.52M50.93M54.81M
Depreciation & Amortization6.37M5.28M5.9M6.02M7.62M
EBITDA56.66M49.3M45.99M41.31M30.23M
EBITDA Margin38.3%32.5%30.9%28.9%22.0%
Operating Income50.27M46.54M40.05M35.19M22.59M
Operating Margin34.0%30.7%27.0%24.6%16.4%
Interest Income14K168K820K125K111K
Interest Expense1.67M1.21M862K2.6M4.76M
Other Income / Expenses(1.65M)(3.73M)(83K)(2.5M)(4.75M)
Income Before Tax48.62M42.82M39.96M32.69M17.84M
Pre-Tax Margin32.9%28.2%26.9%22.9%13.0%
Income Tax Expense11.16M11.02M8.99M7.91M6.24M
Net Income37.47M31.8M30.97M24.78M11.6M
Net Margin25.3%21.0%20.8%17.3%8.4%
EPS (Basic)1.471.281.261.050.52
EPS (Diluted)1.461.271.251.040.52
Weighted Avg Shares25.42M24.92M24.54M23.72M22.38M
Weighted Avg Shares (Diluted)25.64M25.05M24.67M23.74M22.4M

National Research Corporation

NASDAQ:NRC

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.